Clover Health Earns 4-Star CMS Rating, Anticipates Growth
Company Announcements

Clover Health Earns 4-Star CMS Rating, Anticipates Growth

The latest announcement is out from Clover Health Investments ( (CLOV) ).

Clover Health Investments, Corp. has announced a CMS rating upgrade for its PPO Medicare Advantage plans to 4 Stars for 2025, a boost that is expected to increase the company’s benchmark rates by 5% due to quality bonus payments for payment year 2026. This advancement will enable Clover Health to enhance member benefits and support future growth by delivering greater value. The improved rating reflects Clover’s strong performance in healthcare quality measures, particularly in Medication Adherence and Member Experience.

See more insights into CLOV stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyClover Health price target raised to $4.20 from $3.20 at Canaccord
TipRanks Auto-Generated NewsdeskClover Health Reports Strong Financial Growth in Q3 2024
TheFlyClover Health reports Q3 EPS (2c), consensus (4c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App